Investor Calls: Biotech and Novo Discussion

Cramer answers callers about biotech leaders, comparing Novo Nordisk and Eli Lilly and recommending holds versus buys.

Play episode from 09:46

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!